Records containing: Malignant Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-10-20Optical Biopsy of Human Skin in Conjunction With Laser Treatment
-
CLINICAL_TRIALS study record update · 2022-08-03A Multicenter, Two Part, Phase 1B Study Evaluating Alternative Routes of Administration of CMP-001 in Combination With Pembrolizumab in Subjects With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2022-06-15Phase II Study of AZD6738 in Combination With Durvalumab (MEDI4736), in Patients With Metastatic Solid Tumor as Salvage Treatment
-
CLINICAL_TRIALS study record update · 2022-05-20A Phase 1 Study of E6201 Plus Dabrafenib for the Treatment of Central Nervous System Metastases (CNS) From BRAF V600-Mutated Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2022-04-27The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in Solid Tumors
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-04-07Phase I/II Study of Immunization With Multiple Peptides Mixed With the Immunological Adjuvant CpG 7909 or Montanide ISA51 in HLA-A2 Patients With Metastatic Cutaneous Melanoma
-
CLINICAL_TRIALS study record update · 2022-04-05GI Complications in Cancer Immunotherapy Patients
-
CLINICAL_TRIALS study record update · 2022-03-10Adaptive Study of the Safety, Tolerability & Efficacy of Autologous γδ T Lymphocyte Therapy (ImmuniCell®) in Patients With Advanced Cancers Refractory to Current Treatment or Have Indolent Disease for Which Immunotherapy May be Beneficial
-
CLINICAL_TRIALS study record update · 2022-03-03An Observational Study Design to Detect if Co-stimulatory Markers and Vitamin D Status in Anti-PD-1 Treated Advanced Melanoma Patients Can Predict Treatment Outcome
-
CLINICAL_TRIALS study record update · 2022-02-04An Open-label Phase Ib/II, Multi-center Study of 4SC-202 in Combination With Pembrolizumab in Patients With Unresectable Stage III/Metastatic Stage IV Cutaneous Melanoma Primary Refractory/Non-responding to Prior Anti-PD-1 Therapy
-
CLINICAL_TRIALS study record update · 2021-12-10Pre Transplantation Melanoma : Retrospective and Prospective Multicenter Observational Study
-
CLINICAL_TRIALS study record update · 2021-11-22A Pilot Study Using Programmed Cell Death 1 + Selected Cell Therapy With Durvalumab (MEDI4736) and Tremelimumab in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2021-10-12PET Imaging of the Immune System Using New Nucleotide Analog Probes
-
CLINICAL_TRIALS study record update · 2021-08-12A Phase II Trial of PLX3397 in the Treatment of KIT Mutated Advanced Acral and Mucosal Melanoma
-
CLINICAL_TRIALS study record update · 2021-07-21Phase I/II Study of Immunization With the MAGE-3.A1 Peptide Mixed With the Immunological Adjuvant CpG 7909 in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2021-07-07Exploratory Study on Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2021-05-13An Exploratory Study of PD-1 Antibody(Toripalimab) or Combining With Temozolomide for Injection in the Treatment of Advanced/Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2021-05-03Pilot Study of 1cm Versus 2cm Margins for the Surgical Treatment of cT2N0M0 Melanoma
-
CLINICAL_TRIALS study record update · 2021-04-15A Randomized Controlled Phase II Clinical Trial With Intradermal IMO-2125 (Tilsotolimod) in pT3-4 cN0M0 Melanoma
-
CLINICAL_TRIALS study record update · 2021-03-22A Phase 1b, Open-label, Multicenter, Multidose, Dose-escalation Study of BMS-936558 (MDX-1106) in Combination With Ipilimumab in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2021-02-25An Open-label, Phase IB Study of NEO-PV-01 + Adjuvant With Nivolumab in Patients With Melanoma, Non-Small Cell Lung Carcinoma or Transitional Cell Carcinoma of the Bladder
-
CLINICAL_TRIALS study record update · 2021-02-16A Randomized Phase I / II Open Label, Multicentre Study of Encorafenib Plus Binimetinib and PD-1 Antibody Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
-
CLINICAL_TRIALS study record update · 2021-02-03Neoadjuvant Treatment With the Combination of Vemurafenib, Cobimetinib and Atezolizumab in Limited Metastasis of Malignant Melanoma (AJCC Stage IIIC/IV) and Integrated Biomarker Study: a Single Armed, Two Cohort, Phase II EADO Trial NEO-VC
-
CLINICAL_TRIALS study record update · 2021-01-20Phase 2 Study of the Anti-Angiogenesis Agent Axitinib (AG-013736) in Patients With Stage III Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2021-01-05A Phase Ib Tissue Collection Study of Pembrolizumab (MK-3475) in Subjects With Resectable Advanced Melanoma